![]() ![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||||||||
|
Welcome to Redding Thermography
This site provides information about the role of breast thermography in risk assessment, prevention, and early detection of breast cancer. Our mission is to empower women to be pro-active regarding their breast health. We strive to provide the highest quality imaging services to aid women and their health care providers in determining the necessity for further evaluation, and subsequent prevention and/or treatment.
The following illustrates the role of thermography (also called thermal imaging, digital infrared imaging, medical infrared imaging, and computerized infrared imaging) in prevention and early detection of breast cancer, and as a possible method of monitoring progress of newly proposed cancer treatments.
Current statistics reveal that 1 in 8 women will develop invasive cancer, based of a life expectancy of 85 years (1). If treated in the earliest stages, breast cancer cure rates greater than 95% are possible (3,5). The combined use of thermography, physical exams, and properly executed self-exams provide women with a 98% detection rate of all early stage cancers (5). Studies also reveal up to 61% increase in survival rates when thermography is added to a women's regular breast check-ups (5).
Women with a family history are at a greater risk for getting breast cancer, but 80% of women who get breast cancer have NO family history of the disease (1). Thermography provides much needed individual breast cancer risk assessment. Certain thermographic risk markers can warn a woman that she needs to be vigilant in monitoring her breast health. This gives her time to make changes to lower as many risk factors as possible and initiate a more anti-carcinogenic lifestyle.
The single greatest risk factor for developing breast cancer is a woman's lifetime exposure of the breasts to estrogen. It has been determined that a woman can have up to 50 times more estrogen in her breast tissue than her blood levels indicate (5). With the help of her doctor, a woman make changes to balance her hormone levels and therefore lower her risk. Doctors can also use thermography before and after initiating any treatment that affects breast physiology, such as chemoprevention (Tamoxifin), chemotherapy, and HRT. Breast cancer is also the number one cause of death of women aged 22 to 59 (1). Breast cancers in younger women are usually more aggressive and have poorer survival rates. Mammography is difficult to interpret for pre-menopausal women due to the density of the breast.
In addition, women who are on hormonal replacement therapy, or those with large breasts, fibrocystic breasts, or breast enhancements cause reading difficulties for mammograms. Thermography interpretation is not hindered by these situations and is safe for women who are pregnant. But keep in mind that thermography is beneficial for women of all ages and has an average accuracy rate of 90%. According to a study published in the January 2003 publication of the American Journal of Radiology, thermography was determined to be a safe, noninvasive, and valuable adjunct to mammography in determining whether a lesion was benign or malignant (7). DII was found to have a 97% sensitivity for detecting breast cancer in women who had a suspicious mammogram requiring a biopsy (7). Thermography offers women and their health care providers additional beneficial information when a mammogram is normal, equivocal, or when considering the need for a biopsy. Unlike technologies such as mammography, MRI, CT, ultrasound, or PET scans which detect a the presence of an existing tumor, breast thermography has the ability to give a warning signal far in advance of invasive tumor growth. Recent information suggests that DII may also help to monitor the effects of some of the newly proposed and deemed "promising" antiangiogenic cancer treatments (2,3). It is clear that breast thermography offers women information that no other testing procedure can provide. Our Staff William Amalu, DC, DABCT, DIACT, FIACT Dr. Amalu brings over a decade of thermal imaging experience to patient care. In partnership with William Hobbins, MD, FACS, FABCT, of Thermal Image Analysis, our center provides over 40 years of clinical excellence in thermographic analysis and interpretation. As the President of the International Academy of Clinical Thermology, Dr. Amalu instructs physicians worldwide on the science and interpretation of thermal imaging.
References: 1. ACS Breast Cancer Guidelines and Statistics, 2005-2006. 2. Ahlgren P., M.D., et al. "Is it Time to Reassess the value of Infrared Imaging?" Primary Care and Cancer (NCI) 18.2 (1988). 3. Gamigami P., M.D. Atlas of Mammography; New Early Signs of Breast Cancer. Blackwell Science, 1996. 4. Gautherie M., Ph.D. "Thermobiological Assessment of Benign and Malignant Breast Diseases."Am. J. Obstet. Gynecol 147. 8 (1983): 861-869. 5. Jefcoate, C.R., et al. Chapter 5; "Tissue Specific Synthesis and Oxidative Metabolism of Estrogens." Journal of the National Cancer Institute 27 (2000): 95-112. 6. Haehnel P., M.D., et.al. "Long-Term Assessment of Breast Cancer Risk by Thermal Imaging." Biomedical Thermology (1980): 279-301. 7. Parisky Y. R., et al. "Efficacy of Computerized Infrared Imaging Analysis to Evaluate Mammographically Suspicious Lesions." American Journal of Radiology Jan. 2003: 263-269. |
||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
© Copyright 2005 Redding Thermography - Hudson and Hodge Chiropractic Inc. - Legal Disclaimer |
||||||||||||||||||||||||||||||||||||||||||||||||